Literature DB >> 26916148

Echocardiographic quantification of systolic function during atrial fibrillation: probing the 'ten heart cycles' rule.

Flemming Javier Olsen1, Peter Godsk Jørgensen1,2, Maria Dons1, Jesper Hastrup Svendsen2,3, Lars Køber2,3, Jan Skov Jensen1,2, Tor Biering-Sørensen1,4.   

Abstract

It is often difficult to provide an exact echocardiographic measure of left ventricular systolic function in patients with atrial fibrillation, partly because of the varying cycle length affecting pre and afterload and partly because of the increased heart rate often accompanying this arrhythmia. We sought to elucidate two points: whether it would be possible to correct for the cyclic variance in systolic output, and if global longitudinal strain is preferable to the left ventricular ejection fraction at evaluating systolic function during atrial fibrillation.

Entities:  

Keywords:  atrial fibrillation; echocardiography; global longitudinal strain; myocardial deformation; systolic function

Mesh:

Year:  2016        PMID: 26916148     DOI: 10.2217/fca.15.77

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  3 in total

1.  Global longitudinal strain corrected by RR interval is a superior predictor of all-cause mortality in patients with systolic heart failure and atrial fibrillation.

Authors:  Daniel Modin; Morten Sengeløv; Peter Godsk Jørgensen; Niels Eske Bruun; Flemming Javier Olsen; Maria Dons; Thomas Fritz Hansen; Jan Skov Jensen; Tor Biering-Sørensen
Journal:  ESC Heart Fail       Date:  2017-10-11

Review 2.  Echo and heart failure: when do people need an echo, and when do they need natriuretic peptides?

Authors:  Daniel Modin; Ditte Madsen Andersen; Tor Biering-Sørensen
Journal:  Echo Res Pract       Date:  2018-04-24

Review 3.  Role of confirmed and potential predictors of an unfavorable outcome in heart failure in everyday clinical practice.

Authors:  Anna Chuda; Maciej Banach; Marek Maciejewski; Agata Bielecka-Dabrowa
Journal:  Ir J Med Sci       Date:  2021-02-17       Impact factor: 1.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.